Dr Mike Leach has developed compounds, known as UoG-alpha and UoG-beta, that can inhibit the multiple cytokine proteins that can cause death by respiratory collapse, following Covid 19 infection. These compounds can be used within a drug therapy to prevent our immune system from disabling the body’s lung function during a cytokine storm; one of the contributing factors in Covid-19 deaths. This treatment could potentially also help protect cancer and organ transplant patients.
The School of Nursing and Midwifery at the University of Derby offers high-quality education from Nursing Associate degrees and Advanced Clinical Practitioner apprenticeships to a range of undergraduate and postgraduate…
Anthony Luvera from the Centre for Arts, Memory and Communities at Coventry University has conducted socially engaged photographic research that has looked to influence attitudes towards homelessness with various audiences, with…
Coventry University researchers, Professor Sarah Whatley, Dr Rosamaria Cisneros and Dr Karen Wood from the Centre for Dance Research (C-DaRE) have worked with IT developers, custodians of cultural content, renowned dance artists,…
